secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lakeside Holding Ltd (LSH)
CIK:        0001996192
Form:       8-K
Filed at:   2025-02-14T23:59:59+00:00
Accession:  0001213900-25-014389
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lakeside Q2 revenue fell 27% to $3.6M; net loss $1.9M vs prior-year profit
--------------------------------------------------------------------------

- Q2 revenue $3.6M down 26.9% YoY; net loss $1.9M vs net income $0.06M.
- H1 revenue $7.7M down 15.3%; gross profit collapsed to $0.5M from $1.7M; margin 5.1% vs 18.9%.
- Airfreight volume halved to 4,459 tons; Asia-based customer revenue up 29.4% in H1.
- Acquired Hupan Pharmaceutical for $0.6M; pharma segment added $0.2M in Q2.
- Signed $1.5M one-year drug supply deal with Sinopharm subsidiary; Dallas warehouse doubled.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1996192/000121390025014389/0001213900-25-014389-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1996192/000121390025014389/ea0231248-8k_lakeside.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-014389

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer